CXCR3 ameliorates neutrophil-dependent disease severity in SARS-CoV-2 infection by regulating CD4+ T cell recruitment
Md Jashim Uddin, Claire Fleming, Nick R. Natale, Duncan Hart, Brett Moreau, Anthony Day, Judith Allen, William A. Petri · 2026
Read CXCR3 ameliorates neutrophil-dependent disease severity in SARS-CoV-2 infection by regulating CD4+ T cell recruitment by Md Jashim Uddin, Claire Fleming, Nick R. Natale, Duncan Hart, Brett Moreau, Anthony Day, Judith Allen, William A. Petri (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13294051.txt.
Description
Md Jashim Uddin and colleagues probe a protective immune pathway in mouse COVID in a 2026 study. Lung RNA data showed sharp rises in CXCL9, CXCL10, and CXCL11 after infection with mouse-adapted SARS-CoV-2, along with their shared receptor CXCR3. Flow checks linked stronger arrival of CXCR3-bearing T cells and other immune cells to milder illness.
Blocking CXCR3 worsened disease, cut T cell entry, and let neutrophils flood in. Removing neutrophils eased that harm, and mice lacking adaptive immunity lost the protection. Transfer of normal CD4 T cells, but not CXCR3-deficient ones, restored defense. The axis appears to guard lungs by holding neutrophil damage in check.
Catalog record
| CREATOR | Md Jashim Uddin, Claire Fleming, Nick R. Natale, Duncan Hart, Brett Moreau, Anthony Day, Judith Allen, William A. Petri |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 42561 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |